Answers are grounded in this paper and cite their sources.
Systematic review reveals adipocytes' dual role in cancer progression, suggesting novel therapeutic targets.
In recent years, the dual regulatory role of adipocytes in the tumor microenvironment (TME) has emerged as a critical focus in cancer research. Advances in the fields of metabolic biology and tumor immunology have shown that adipocytes play a crucial role in tumor occurrence, progression, and treatment outcome by secreting adipokines, regulating metabolic reprogramming, and mediating immunosuppressive networks. This article systematically reviews the physiological functions of adipose tissue and its intricate crosstalk with cancer cells, with particular emphasis on dual metabolic and immune mechanisms by which adipocytes dynamically modulate tumor progression within the TME. Furthermore, by integrating preclinical research and translational medicine evidence, a precise treatment framework targeting the interaction between fat and tumor is proposed, providing theoretical basis for the development of metabolic immune combination therapy.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: